...
首页> 外文期刊>The Journal of Neuroscience: The Official Journal of the Society for Neuroscience >PKA Reduces the Rat and Human KCa3.1 Current, CaM Binding, and Ca2+ Signaling, Which Requires Ser332/334 in the CaM-Binding C Terminus
【24h】

PKA Reduces the Rat and Human KCa3.1 Current, CaM Binding, and Ca2+ Signaling, Which Requires Ser332/334 in the CaM-Binding C Terminus

机译:PKA减少大鼠和人类的KCa3.1电流,CaM结合和Ca2 +信号传导,这需要在CaM结合C末端中的Ser332 / 334

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The Ca2+-dependent K+ channel, KCa3.1 (KCNN4/IK/SK4), is widely expressed and contributes to cell functions that include volume regulation, migration, membrane potential, and excitability. KCa3.1 is now considered a therapeutic target for several diseases, including CNS disorders involving microglial activation; thus, we need to understand how KCa3.1 function is regulated. KCa3.1 gating and trafficking require calmodulin binding to the two ends of the CaM-binding domain (CaMBD), which also contains three conserved sites for Ser/Thr kinases. Although cAMP protein kinase (PKA) signaling is important in many cells that use KCa3.1, reports of channel regulation by PKA are inconsistent. We first compared regulation by PKA of native rat KCa3.1 channels in microglia (and the microglia cell line, MLS-9) with human KCa3.1 expressed in HEK293 cells. In all three cells, PKA activation with Sp-8-Br-cAMPS decreased the current, and this was prevented by the PKA inhibitor, PKI14-22. Inhibiting PKA with Rp-8-Br-cAMPS increased the current in microglia. Mutating the single PKA site (S334A) in human KCa3.1 abolished the PKA-dependent regulation. CaM-affinity chromatography showed that CaM binding to KCa3.1 was decreased by PKA-dependent phosphorylation of S334, and this regulation was absent in the S334A mutant. Single-channel analysis showed that PKA decreased the open probability in wild-type but not S334A mutant channels. The same decrease in current for native and wild-type expressed KCa3.1 channels (but not S334A) occurred when PKA was activated through the adenosine A2a receptor. Finally, by decreasing the KCa3.1 current, PKA activation reduced Ca2+-release-activated Ca2+ entry following activation of metabotropic purinergic receptors in microglia.
机译:依赖于Ca2 +的K +通道KCa3.1(KCNN4 / IK / SK4)广泛表达,并有助于细胞功能,包括体积调节,迁移,膜电位和兴奋性。 KCa3.1现在被认为是多种疾病的治疗靶标,包括涉及小胶质细胞活化的中枢神经系统疾病;因此,我们需要了解如何调节KCa3.1功能。 KCa3.1的门控和运输要求钙调蛋白与CaM结合域(CaMBD)的两端结合,CaMD结合域还包含三个保守的Ser / Thr激酶位点。尽管cAMP蛋白激酶(PKA)信号在许多使用KCa3.1的细胞中很重要,但有关PKA调节通道的报道却不一致。我们首先比较了小胶质细胞(和小胶质细胞系MLS-9)中天然大鼠KCa3.1通道的PKA调控与在HEK293细胞中表达的人KCa3.1的对比。在所有三个细胞中,用Sp-8-Br-cAMPS激活PKA会降低电流,这可以通过PKA抑制剂PKI14-22来阻止。用Rp-8-Br-cAMPS抑制PKA可增加小胶质细胞的电流。突变人KCa3.1中的单个PKA位点(S334A)消除了PKA依赖性调节。 CaM亲和色谱表明CaM与KCa3.1的结合由于S334的PKA依赖性磷酸化而降低,并且在S334A突变体中不存在这种调节。单通道分析表明,PKA降低了野生型的开放概率,但不降低S334A突变体通道的开放概率。当通过腺苷A2a受体激活PKA时,天然和野生型表达的KCa3.1通道(而不是S334A)的电流减少量相同。最后,通过降低KCa3.1电流,在小胶质细胞中代谢型嘌呤能受体激活后,PKA激活减少了Ca2 +释放激活的Ca2 +进入。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号